BRIEF published on 06/26/2025 at 17:48, 5 months 8 days ago Dermapharm Holding SE Approves EUR 0.90 Dividend Per Share Sustainability Dividend AGM Financial Outlook Dermapharm
PRESS RELEASE published on 06/26/2025 at 17:43, 5 months 8 days ago Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 0.90 per share Dermapharm Holding SE's Annual General Meeting approves divident distribution of EUR 0.90 per share for 2024, confirms 2025 outlook and ratifies Board actions Annual General Meeting Financial Year 2024 Dividend Distribution Dermapharm Holding SE EUR 0.90 Per Share
BRIEF published on 05/15/2025 at 07:35, 6 months 21 days ago Dermapharm Holding SE répond aux attentes du premier trimestre 2025 et renforce ses prévisions pour l'ensemble de l'année Croissance Des Revenus Baisse De L'EBITDA Orientation Pour L'année Entière Produits Pharmaceutiques De Marque Dermapharm T1 2025
BRIEF published on 05/15/2025 at 07:35, 6 months 21 days ago Dermapharm Holding SE Meets Q1 2025 Expectations, Reinforces Full-Year Forecast Revenue Growth Full-year Guidance EBITDA Decline Branded Pharmaceuticals Dermapharm Q1 2025
PRESS RELEASE published on 05/15/2025 at 07:30, 6 months 21 days ago Dermapharm Holding SE performs in line with projections in Q1 2025, confirms full-year guidance Dermapharm Holding SE reports Q1 2025 results in line with projections, confirming full-year guidance. Revenue increases by 1.2% year-on-year to EUR 302.4 million Adjusted EBITDA Revenue Growth Dermapharm Holding SE Full-year Guidance Q1 2025 Results
BRIEF published on 03/28/2025 at 07:35, 8 months 8 days ago Les résultats financiers de Dermapharm en 2024 dépassent les attentes Augmentation Des Revenus Croissance De L'EBITDA Résultats Financiers 2024 Produits Pharmaceutiques De Marque Dermapharm
BRIEF published on 03/28/2025 at 07:35, 8 months 8 days ago Dermapharm's 2024 Financial Performance Exceeds Expectations Revenue Increase EBITDA Growth Branded Pharmaceuticals Financial Results 2024 Dermapharm
PRESS RELEASE published on 03/28/2025 at 07:30, 8 months 8 days ago Successful financial year 2024: Dermapharm increases revenue and exceeds EBITDA guidance Dermapharm Holding SE reports successful financial year 2024 with increased revenue and exceeded EBITDA guidance. Full details in Annual Report Revenue Increase Financial Year 2024 EBITDA Guidance Annual Report Dermapharm Holding SE
BRIEF published on 03/14/2025 at 07:35, 8 months 22 days ago Dermapharm Holding SE augmente son chiffre d'affaires et dépasse les prévisions d'EBITDA Proposition De Dividende Produits De Santé Croissance De L'EBITDA Produits Pharmaceutiques De Marque Chiffre D'affaires De Dermapharm
BRIEF published on 03/14/2025 at 07:35, 8 months 22 days ago Dermapharm Holding SE Increases Revenue and Exceeds EBITDA Guidance Dividend Proposal EBITDA Growth Healthcare Products Branded Pharmaceuticals Dermapharm Revenue
Published on 12/05/2025 at 02:35, 7 hours 59 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 9 hours 34 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 11 hours 29 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 11 hours 34 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 10:15, 19 minutes ago Wuxi’s Liangxi District: Where 3,000 Years of Jiangnan Culture Thrives
Published on 12/05/2025 at 09:40, 54 minutes ago Chery Partners with 2025 Asian Youth Para Games, Taking Center Stage in Global Sports with Passion and Aspiration
Published on 12/05/2025 at 09:30, 1 hour 4 minutes ago REPLOID Group AG: Exhibitor at the BIOGAS Convention & Trade Fair in Nuremberg, Germany
Published on 12/05/2025 at 09:05, 1 hour 29 minutes ago Transforming Football: IBM and Bayer 04 Leverkusen Use AI for Superior Game Analysis
Published on 12/05/2025 at 09:00, 1 hour 34 minutes ago Original-Research: DEMIRE AG (von NuWays AG): BUY
Published on 12/05/2025 at 08:45, 1 hour 49 minutes ago Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 1 hour 49 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/05/2025 at 08:42, 1 hour 52 minutes ago ENGIE - déclaration mensuelle du nombre total d'actions et de droits de vote composant le capital au 30 novembre 2025
Published on 12/04/2025 at 18:14, 16 hours 20 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 16 hours 34 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
